Skip to Content

Carbetapentane / chlorpheniramine / phenylephrine Pregnancy and Breastfeeding Warnings

Carbetapentane / chlorpheniramine / phenylephrine is also known as: Carbaphen 12, Exratuss, Tannate-12, Tanni-Hist 12 RF, Tannic-12, Tussi-12 (old formulation), XiraTuss

Carbetapentane / chlorpheniramine / phenylephrine Pregnancy Warnings

Carbetapentane/chlorpheniramine/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbetapentane/chlorpheniramine/phenylephrine is only recommended for use during pregnancy when benefit outweigh risk.

See references

Carbetapentane / chlorpheniramine / phenylephrine Breastfeeding Warnings

There are no data on the excretion of carbetapentane/chlorpheniramine/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. XiraTuss (carbetapentane/chlorpheniramine/phenylephrine)." Cypress Pharmaceutical Inc, Madison, MS.

References for breastfeeding information

  1. "Product Information. XiraTuss (carbetapentane/chlorpheniramine/phenylephrine)." Cypress Pharmaceutical Inc, Madison, MS.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide